Sotera Health Company (SHC)
Sotera Health Company (SHC) is a healthcare company (diagnostics & research) based in the United States. The share price is $16.10, down 0.92% on the day, which values the company at $4.6B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.
Key facts
- Share price
- $16.10−0.92% today
- Market value
- $4.6B
- P/E ratio
- 26.8×last 12 months
- Forward P/E
- 15.1×
- Funk Score
- 57/100
- Against its own history
- Below its usual priceusual price $20.33
- 200-week average
- $15.117% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Sotera Health Company in more detail
SHC trades at 26.8× its last twelve months' earnings, 15.1× next year's expected earnings, 3.7× sales. Measured against its own history, the price is 21% below what its usual multiples would imply ($20.33) — below its usual price. It sits 7% above its 200-week average of $15.11.
Over the last five fiscal years Sotera Health Company has compounded revenue 7.3% a year, free cash flow 17.3% a year. Its Funk Score is 57 out of 100 (financial strength 2.3, profitability 6.5, growth 6.5, value 7.4, each out of 10).
In its favour: Operating margin is expanding; Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Share count keeps rising.
6 of the superinvestors tracked here hold SHC, including Adam Katz (6.6% of the portfolio), Anthony Bozza (3.4% of the portfolio), Anand Desai (2.2% of the portfolio).
Superinvestors holding SHC
6 of the investors tracked here report a position in their latest 13F filing.
- Adam Katz Irenic Capital Management6.57% of portfolio · $91.3M · added · Q2 2026
- Anthony Bozza Lakewood Capital3.44% of portfolio · $64.2M · trimmed · Q3 2026
- Anand Desai Darsana Capital Partners2.15% of portfolio · $479.3M · added · Q2 2026
- David Einhorn Greenlight Capital1.88% of portfolio · $73.4M · added · Q2 2026
- Fred DiSanto Ancora0.92% of portfolio · $47.6M · new · Q2 2026
- Eric Bannasch Cadian Capital Management0.54% of portfolio · $6.5M · Q3 2026
Sotera Health Company (SHC): questions and answers
What is SHC's P/E ratio?
Sotera Health Company trades at 26.8× its last twelve months' earnings and 15.1× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 57.4× to 93.6×, with a median of 75.4×.
What is SHC's PEG ratio?
Sotera Health Company's PEG ratio is 1.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Sotera Health Company's market cap?
Sotera Health Company is valued at $4.6B at a share price of $16.10.
Is SHC overvalued or undervalued?
Against its own history, SHC is below its usual price: the price is 21% below the $20.33 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is SHC above its 200-week moving average?
Yes. SHC is 6.6% above its 200-week average of $15.11. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Sotera Health Company growing?
Over the last five fiscal years Sotera Health Company's revenue grew 7.3% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Sotera Health Company (SHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SHC
Underlying data: Yahoo Finance; company filings with the SEC.